3230-94-2

3230-94-2 structure

Name: L-Ornithine L-aspartate salt
Chemical Name: (2S)-2-aminobutanedioic acid,(2S)-2,5-diaminopentanoic acid
CAS Number: 3230-94-2
Molecular Formula: C₉H₁₉N₃O₆
Molecular Weight: 265.264
Catalog: Pharmaceutical intermediate Heterocyclic compound Pyrimidine compound Bromopyrimidine
Create Date: 2018-09-12 11:49:33
Modify Date: 2025-08-20 22:47:11
L-Ornithine L-aspartate is a stable salt of two natural nonessential L-amino acids: ornithine and aspartic acid. L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis[1].

Name	(2S)-2-aminobutanedioic acid,(2S)-2,5-diaminopentanoic acid
Synonyms	L-Ornithine L-Aspartate Salt L-Ornithine L-Aspartate L-Ornithine-L-Aspartate L-Aspartic acid - L-ornithine (1:1) EINECS 221-772-7 L-OrnithineL-aspartatesalt (S)-2,5-Diaminopentanoic acid L-aspartate salt Hepa-Merz (TN) L-Ornithin-L-aspartat L-Aspartic acid, compd. with L-ornithine (1:1) MFCD00058084 (S)-2,5-Diaminopentanoic acid compound with (S)-2-aminosuccinic acid

Description	L-Ornithine L-aspartate is a stable salt of two natural nonessential L-amino acids: ornithine and aspartic acid. L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease
References	[1]. Sikorska H, et al. [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency]. Pol Merkur Lekarski. 2010 Jun;28(168):490-5.

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 85IPAE "Modern Pharmaceuticals of Japan, III," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1968 Volume(issue)/page/year: -,91,1968

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,164,1982

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,164,1982

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 85IPAE "Modern Pharmaceuticals of Japan, III," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1968 Volume(issue)/page/year: -,91,1968

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes	Xi: Irritant;
Risk Phrases	R36/37/38
Safety Phrases	S26-S37/39
RIDADR	NONH for all modes of transport
WGK Germany	2
RTECS	CI9463000
HS Code	2922499990

HS Code	2922499990
Summary	HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%